IFNG and cancer: The FGF/FGFR system, on the other hand, cooperates with this context as it is also known to inhibit IFN-γ signaling (Adachi et al., 2022), and inhibiting the FGF/FGFR system is required to boost checkpoint inhibitor cancer immunotherapy (Ruan et al., 2023).